HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells.

Abstract
We have previously shown that the toxic pro-oxidant methylselenol is released from selenomethionine (SeMET) by cancer cells transformed with the adenoviral methionine alpha,gamma-lyase (methioninase, MET) gene cloned from Pseudomonas putida. Methylselenol damaged the mitochondria via oxidative stress, and caused cytochrome c release into the cytosol thereby activating caspase enzymes and thereby apoptosis. However, gene therapy strategies are less effective if tumor cells overexpress the antiapoptotic mitochondrial protein bcl-2. In this study, we investigated whether rAdMET/SeMET was effective against bcl-2-overproducing A549 lung cancer cells. We established two clones of the human lung cancer A549 cell line that show moderate and high expression levels of bcl-2, respectively, compared to the parent cell line, which has very low bcl-2 expression. Staurosporine-induced apoptosis was inhibited in the bcl-2-overproducing clones as well as in the parental cell line. In contrast to staurosporine, apoptosis was induced in the bcl-2-overproducing clones as well as the parental cell line by AdMET/SeMET. Apoptosis in the rAdMET-SeMET-treated cells was determined by fragmentation of nuclei, and release of cytochrome c from mitochondria to the cytosol. A strong bystander effect of AdMET/SeMET was observed on A549 cells as well as the bcl-2-overproducing clones. rAdMET/SeMET prodrug gene therapy is therefore a promising novel strategy effective against bcl-2 overexpression, which has blocked other gene therapy strategies.
AuthorsNorio Yamamoto, Anshu Gupta, Mingxu Xu, Kenji Miki, Yoshihide Tsujimoto, Hiroyuki Tsuchiya, Katsuro Tomita, A R Moossa, R M Hoffman
JournalCancer gene therapy (Cancer Gene Ther) Vol. 10 Issue 6 Pg. 445-50 (Jun 2003) ISSN: 0929-1903 [Print] England
PMID12768189 (Publication Type: Journal Article)
Chemical References
  • Coloring Agents
  • Oxidants
  • Proto-Oncogene Proteins c-bcl-2
  • Tetrazolium Salts
  • Thiazoles
  • Cytochromes c
  • Selenomethionine
  • Carbon-Sulfur Lyases
  • L-methionine gamma-lyase
  • thiazolyl blue
  • Staurosporine
  • Bisbenzimidazole
Topics
  • Apoptosis
  • Bisbenzimidazole (pharmacology)
  • Blotting, Western
  • Carbon-Sulfur Lyases (genetics)
  • Cell Line, Tumor
  • Cell Nucleus (metabolism)
  • Cell Survival
  • Coloring Agents (pharmacology)
  • Cytochromes c (metabolism)
  • Cytosol (metabolism)
  • DNA Fragmentation
  • Enzyme-Linked Immunosorbent Assay
  • Genetic Therapy (methods)
  • Humans
  • Lung Neoplasms (metabolism, therapy)
  • Mitochondria (metabolism)
  • Models, Biological
  • Oxidants (pharmacology)
  • Oxidative Stress
  • Proto-Oncogene Proteins c-bcl-2 (biosynthesis)
  • Pseudomonas putida (genetics)
  • Selenomethionine (metabolism)
  • Staurosporine (pharmacology)
  • Tetrazolium Salts (pharmacology)
  • Thiazoles (pharmacology)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: